{"timestamp": 1771594804.8614078, "value": {"ticker": "VRAX", "company_name": "Virax Biolabs Group Limited", "short_name": "Virax Biolabs Group Limited", "sector": "Healthcare", "industry": "Biotechnology", "country": "United Kingdom", "market_cap": 1670272, "float_shares": 6157435, "shares_outstanding": 7423432, "short_ratio": 0.14, "short_percent_of_float": 0.0093, "shares_short": 65207, "shares_short_prior": 95551, "insider_percent_held": 0.048130002, "institution_percent_held": 0.038310003, "total_cash": 3437848, "total_debt": 537993, "total_revenue": 2986, "revenue_growth": -0.675, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": -1607.8832, "debt_to_equity": 10.604, "current_ratio": 11.354, "book_value": 0.812, "price_to_book": 0.2770936, "operating_cashflow": -5405240, "free_cashflow": -3539977, "price": 0.225, "52w_high": 1.95, "52w_low": 0.202, "avg_volume": 5364811, "avg_volume_10d": 156590, "full_time_employees": 19, "audit_risk": 0, "overall_risk": 0}}